v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 13,996,647 $ 10,454,160 $ 24,641,869 $ 21,925,852
General and administrative 4,996,444 4,296,417 9,678,939 8,302,059
Amortization of intangible asset 7,317 7,317 14,633 14,633
Total operating expenses 19,000,408 14,757,894 34,335,441 30,242,544
Loss from operations (19,000,408) (14,757,894) (34,335,441) (30,242,544)
Other income (expense)        
Interest income 1,082,784 324,013 2,443,188 762,532
Other income, net 647,197 0 1,160,931 0
Net loss $ (17,270,427) $ (14,433,881) $ (30,731,322) $ (29,480,012)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.27) $ (0.40) $ (0.48) $ (0.82)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.27) $ (0.40) $ (0.48) $ (0.82)
Weighted-average common shares outstanding, basic (in shares) 64,697,219 35,985,878 64,678,120 35,759,026
Weighted-average common shares outstanding, diluted (in shares) 64,697,219 35,985,878 64,678,120 35,759,026
Other comprehensive loss:        
Unrealized loss from marketable securities $ (165,235) $ 0 $ (487,572) $ 0
Comprehensive Loss $ (17,435,662) $ (14,433,881) $ (31,218,894) $ (29,480,012)